SCHEMBL7542217

SCHEMBL7542217

O=Cc1ccc(/N=N/c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.59
▸ CYP2A6 P11509 2/20 0.59
▸ MAPT P10636 5/20 0.50
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ RAB9A P51151 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ PKM P14618 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ TRPA1 O75762 1/20 0.50
▸ MAPK1 P28482 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ HSD17B10 Q99714 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2301281 1.00 ALDH1A1 (0.59) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL5469857 0.90 CYP2A6 (0.50) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL3074403 0.90 CYP2A6 (0.50) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL9640411 0.82 ALDH1A1 (0.52) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL9640413 0.82 ALDH1A1 (0.52) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL2316309 0.80 ALDH1A1 (0.52) ALDH1A1CYP2A6MAPTMEN1KMT2A
SCHEMBL15355549 0.80 ALDH1A1 (0.63) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL13451257 0.80 ALDH1A1 (0.63) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL15132514 0.79 ALDH5A1 (0.73) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL28987870 0.79 PTGS1 (0.44) ALDH1A1CYP2A6MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106434871-B Methods and compositions for detecting target nucleic acids 德克斯特里蒂诊断公司 2020-08-18 — — CN disclosed
CN-103827317-B Methods and compositions for detecting target nucleic acids 德克斯特里蒂诊断公司 2016-09-07 — — CN disclosed
US-20140121226-A1 SUBSTITUTED XANTHINE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2014-05-01 — — US disclosed
EP-2314713-A1 OLIGONUCLEOTIDE PROBE, AND USE THEREOF National University Corporation Nagoya University (JP) 2011-04-27 — — EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 — — US disclosed
US-4285852-A Anisotropic wholly aromatic polyester derived from 4-hydroxy-4'-carboxy azobenzene and process for preparation CELANESE CORPORATION (US) 1981-08-25 — — US disclosed
US-3987037-A RADIATION-SENSITIVE FREE RADICAL GENERATORS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1976-10-19 — — US disclosed
US-3966678-A Maleic anhydride-polyaldimine prepolymers RHONE-POULENC S.A. (FR) 1976-06-29 — — US disclosed
US-3954475-A Photosensitive elements containing chromophore-substituted vinyl-halomethyl-s-triazines MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1976-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 ALDH1A1 1488/4885CYP2A6 1575/4885MAPT 3240/4885
US-20140121226-A1 SUBSTITUTED XANTHINE DERIVATIVES XDH, CXCR4, CXCR3 ALDH1A1 927/4885CYP2A6 507/4885MAPT 3921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback